Vironova AB

Based on best in class technology Vironova sells products and services to characterize nano-sized particles in the pharmaceutical industry, in nano-materials and for diagnostics. 

Since the founding of the company in 2005, Vironova has developed drug candidates and supplied nano-characterization services with aid of the proprietary technology. Vironova springs out of a drug development project at the Karolinska Institute in Stockholm. By broadening the application area for the nano-characterization technology and combining it with expertise in virology, chemistry, image analysis and transmission electron microscopy, the company has built three business areas; nano-characterization services, nano-characterization systems and drug development.

Kategorier: Biotech

Gå till Vironova ABs hemsida